After participating in this educational activity, attendees should be able to:
1. To understand mechanisms of action of mifepristone in the reproductive system, and the history of the research that led to our understanding of its mechanisms.
2. To be able to cousel women with early pregnancy loss and undesired pregnancy on the evidence-based protocol for medical management.
3.To be aware of how restrictions on mifeprstone affect research and patient care.
Sarita Sonalkar, MD, MPH
Assistant Professor, of Obstetrics and Gynecology, University of Pennsylvania School of Medicine
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Instructional Hours